A novel pretreatment method combining sealing technique with direct injection technique applied for improving biosafety.

AIM People today have a stronger interest in the risk of biosafety in clinical bioanalysis. A safe, simple, effective method of preparation is needed urgently. METHODOLOGY/RESULTS To improve biosafety of clinical analysis, we used antiviral drugs of adefovir and tenofovir as model drugs and developed a safe pretreatment method combining sealing technique with direct injection technique. The inter- and intraday precision (RSD %) of the method were <4%, and the extraction recoveries ranged from 99.4 to 100.7%. Meanwhile, the results showed that standard solution could be used to prepare calibration curve instead of spiking plasma, acquiring more accuracy result. CONCLUSION/DISCUSSION Compared with traditional methods, the novel method not only improved biosecurity of the pretreatment method significantly, but also achieved several advantages including higher precision, favorable sensitivity and satisfactory recovery. With these highly practical and desirable characteristics, the novel method may become a feasible platform in bioanalysis.

[1]  G. di Perri,et al.  UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients. , 2015, Journal of pharmaceutical and biomedical analysis.

[2]  Koji Sudo,et al.  Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry. , 2015, Journal of pharmaceutical and biomedical analysis.

[3]  Ashutosh Pudage,et al.  Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study. , 2008, Journal of pharmaceutical and biomedical analysis.

[4]  Yi Zhang,et al.  Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Dan Cohen,et al.  Capillary compared to venous blood sampling in clozapine treatment: patients׳ and healthcare practitioners׳ experiences with a point-of-care device , 2015, European Neuropsychopharmacology.

[6]  Ye Jiang,et al.  Accuracy assessment on the analysis of unbound drug in plasma by comparing traditional centrifugal ultrafiltration with hollow fiber centrifugal ultrafiltration and application in pharmacokinetic study. , 2013, Journal of chromatography. A.

[7]  C. Eap,et al.  Buprenorphine and norbuprenorphine quantification in human plasma by simple protein precipitation and ultra-high performance liquid chromatography tandem mass spectrometry. , 2013, Journal of pharmaceutical and biomedical analysis.

[8]  Jonathan Y. Richmond,et al.  Biosafety in microbiological and biomedical laboratories , 1999 .

[9]  Andrew Owen,et al.  Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Paola Palumbo,et al.  Bioanalytical method development for quantification of ulifloxacin, fenbufen and felbinac in rat plasma by solid-phase extraction (SPE) and HPLC with PDA detection. , 2016, Journal of pharmaceutical and biomedical analysis.

[11]  Valluru Rajani Kumar,et al.  High throughput LC-MS/MS method for simultaneous determination of zidovudine, lamivudine and nevirapine in human plasma. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Lingyi Kong,et al.  Determination of α-glucosidase inhibitors from Scutellaria baicalensis using liquid chromatography with quadrupole time of flight tandem mass spectrometry coupled with centrifugal ultrafiltration. , 2015, Chinese journal of natural medicines.

[13]  C. Fletcher,et al.  Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  Małgorzata Maciejewska,et al.  A new application of micellar liquid chromatography in the determination of free ampicillin concentration in the drug-human serum albumin standard solution in comparison with the adsorption method. , 2016, Talanta.

[15]  Ye Jiang,et al.  The influence of volume ratio of ultrafiltrate of sample on the analysis of non-protein binding drugs in human plasma. , 2013, The Analyst.

[16]  M. Baram Biotechnological Research on the Most Dangerous Pathogens: Challenges for Risk Governance and Safety Management , 2009 .

[17]  Jae-Gook Shin,et al.  Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2015, Journal of pharmaceutical and biomedical analysis.

[18]  U. Liebchen,et al.  Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  Feng Xu,et al.  Development of a mitochondria-based centrifugal ultrafiltration/liquid chromatography/mass spectrometry method for screening mitochondria-targeted bioactive constituents from complex matrixes: Herbal medicines as a case study. , 2015, Journal of chromatography. A.

[20]  Carlo Torti,et al.  Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. , 2007, International journal of antimicrobial agents.

[21]  C. Devaux,et al.  The hidden face of academic researches on classified highly pathogenic microorganisms. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[22]  Joanna Giebułtowicz,et al.  Application of a novel liquid chromatography/tandem mass spectrometry method for the determination of antazoline in human plasma: Result of ELEPHANT-I [ELEctrophysiological, pharmacokinetic and hemodynamic effects of PHenazolinum (ANTazoline mesylate)] human pharmacokinetic study. , 2016, Journal of pharmaceutical and biomedical analysis.

[23]  D. S. Domingues,et al.  Analysis of drugs in plasma samples from schizophrenic patients by column-switching liquid chromatography-tandem mass spectrometry with organic-inorganic hybrid cyanopropyl monolithic column. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  Deqing Sun,et al.  Development and validation of a sensitive LC-MS/MS method for the determination of adefovir in human serum and urine. , 2006, Journal of pharmaceutical and biomedical analysis.